USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Advances in Mitochondrial Disease Management
Advances in Mitochondrial Disease Management
Intensifying R&D and Building a Differentiated Pipeline will Bolster the Rapidly Growing Ecosystem.
09-Oct-2023
Global
Description
Mitochondria are vital structures in the human body, and they play an active role in several processes. They are widely recognized as the powerhouses of the cell because of their essential function in energy production. In addition, mitochondria have a significant impact on several functions of the human body; as a result, any dysfunction in mitochondria can lead to a wide range of diseases, from primary to secondary mitochondrial diseases.
Technology advancements around mitochondria have led to a better understanding of its biology and functions, resulting in the emergence of mitochondrial-targeted therapies and the development of innovative pipelines.
Increased interest from government agencies and R&D consortia and networks for mitochondrial diseases have boosted this space's growth.
This Frost & Sullivan study identifies different therapeutic strategies to address various types of mitochondrial dysfunction and key participants working on different strategies; it also examines therapeutic candidates' clinical landscape and identifies 3 key growth opportunities for mitochondrial therapeutics that could potentially transform the market.
Key Questions Covered:
1.What are key drivers and restraints for mitochondrial therapeutics development?
2.Which therapeutic approaches are available?
3.What does the funding and partnership scene look like?
4.Who are the key innovators in this space?
5.What are some important R&D trends?
6.What are the key growth opportunities in this space?
Table of Contents
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Mitochondrial Therapeutics
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Introduction
Etiology of Mitochondrial Diseases
Etiology of Mitochondrial Diseases (continued)
Growth Drivers
Growth Driver Analysis
Growth Driver Analysis (continued)
Growth Restraints
Growth Restraint Analysis
Growth Restraint Analysis (continued)
Scope of Analysis
Mitochondrial Dysfunction and Therapeutic Strategies
Mitochondrial Biogenesis and Therapeutic Strategies
Mitochondrial Biogenesis and Therapeutic Strategies (continued)
Mitophagy: A Commonly Targeted Therapeutic Approach
Innovation Spotlight: Therapeutics that Targets
Mitochondrial-related Oxidative Stress and Therapeutic Strategies
Mitochondrial-related Oxidative Stress and Therapeutic Strategies (continued)
Innovation Spotlight: Therapeutics that Targets Mitochondrial-related Oxidative Stress
Mitochondrial Dynamics and Therapeutic Strategies
Mitochondrial Dynamics and Therapeutic Strategies (continued)
Innovation Spotlight: Therapeutics that Targets Mitochondrial Dynamics
mtDNA Homeostasis and Therapeutic Strategies
Mitochondrial Genome Manipulation and Therapeutic Strategies
Innovation Spotlight: Therapeutics that Targets mtDNA Homeostasis and Mitochondrial Genome Manipulation
Emerging Trends in the Mitochondrial Disease Therapeutic Landscape
Mitochondrial Therapeutics: Clinical Trial Landscape
Clinical Landscape of Mitochondrial Therapies for Key Industry Participants
Clinical Landscape of Mitochondrial Therapies for Key Industry Participants (continued)
R&D Activity Trends: Growing Focus on Applied Research
R&D Innovation Trends
R&D Hubs Focused on Mitochondrial Research
R&D Hubs Focused on Mitochondrial Research (continued)
Therapeutic Strategies for Neurodegenerative Disease Management
Therapeutic Strategies for Metabolic Disease Management
Therapeutic Strategies for Cardiovascular Disease Management
Therapeutic Strategies for Age-related Disease Management
Therapeutic Strategies for Age-related Disease Management (continued)
Therapeutic Strategies for Cancer Management
Therapeutic Strategies for Cancer Management (continued)
Mitochondrial Diseases: Diagnostic and Preventive Strategies
Mitochondrial Diseases: Diagnostic and Preventive Strategies (continued)
Public and Private Funding Promote the Development of Mitochondrial Therapies
Public and Private Funding Promote the Development of Mitochondrial Therapies (continued)
Public and Private Funding Promote the Development of Mitochondrial Therapies (continued)
Partnership Landscape of Companies to Promote the Development of Targeted Protein Degradation Therapeutics
Growth Opportunity 1: Drug Repurposing
Growth Opportunity 1: Drug Repurposing (continued)
Growth Opportunity 2: Advanced Drug-Delivery Approaches
Growth Opportunity 2: Advanced Drug-Delivery Approaches (continued)
Growth Opportunity 3: Accurate Mitochondrial Diagnostics Development
Growth Opportunity 3: Accurate Mitochondrial Diagnostics Development (continued)
Your Next Steps
Why Frost, Why Now?
Legal Disclaimer
| Author | Priyanka Jain |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Healthcare Advances in Mitochondrial Diseases |
| Keyword 2 | Mitochondrial Disorder Treatment Trends |
| Keyword 3 | Mitochondrial Disease Diagnosis Innovations |
| Podcast | No |
| WIP Number | DAB8-01-00-00-00 |